Why is SMO ClinPlus Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 10.68% and Operating profit at 6.98% over the last 5 years
2
Flat results in Mar 26
- DEBT-EQUITY RATIO (HY) Highest at -44.82 %
3
With ROE of 8.90%, it has a very attractive valuation with a 1.46 Price to Book Value
- Over the past year, while the stock has generated a return of 45.09%, its profits have risen by 26.1% ; the PEG ratio of the company is 0.6
4
Market Beating Performance
- The stock has generated a return of 45.09% in the last 1 year, much higher than market (China Shanghai Composite) returns of 16.78%
How much should you hold?
- Overall Portfolio exposure to SMO ClinPlus Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is SMO ClinPlus Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
SMO ClinPlus Co., Ltd.
45.09%
0.74
62.23%
China Shanghai Composite
16.78%
1.20
13.96%
Quality key factors
Factor
Value
Sales Growth (5y)
10.68%
EBIT Growth (5y)
6.98%
EBIT to Interest (avg)
99.11
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.72
Sales to Capital Employed (avg)
0.68
Tax Ratio
11.32%
Dividend Payout Ratio
10.67%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
48.28%
ROE (avg)
9.67%
Valuation Key Factors 
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.46
EV to EBIT
11.87
EV to EBITDA
10.67
EV to Capital Employed
1.84
EV to Sales
1.51
PEG Ratio
0.63
Dividend Yield
NA
ROCE (Latest)
15.50%
ROE (Latest)
8.90%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
3What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -7.49% (YoY
PRE-TAX PROFIT(Q)
At CNY 12.58 MM has Grown at 83.19%
NET PROFIT(Q)
At CNY 11.47 MM has Grown at 73.88%
-2What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -44.82 %
Here's what is working for SMO ClinPlus Co., Ltd.
Pre-Tax Profit
At CNY 12.58 MM has Grown at 83.19%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 11.47 MM has Grown at 73.88%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -7.49% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for SMO ClinPlus Co., Ltd.
Debt-Equity Ratio
Highest at -44.82 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






